These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33410623)

  • 1. A study of follicular development and oocyte maturity predicted by transvaginal ultrasound on the day of human chorionic gonadotropin injection.
    Chen X; Liang XW; Fang JH; Chen ZY
    Chin Med J (Engl); 2021 Jan; 134(6):731-733. PubMed ID: 33410623
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. I. Follicular growth and oocyte suitability.
    Plachot M; Mandelbaum J; Cohen JJ; Debache C; Pigeau F; Junca AM
    Fertil Steril; 1985 Feb; 43(2):255-62. PubMed ID: 3917950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound control of clomiphene/human chorionic gonadotropin stimulated cycles for oocyte recovery and in vitro fertilization.
    Hoult IJ; de Crespigny LC; O'Herlihy C; Speirs AL; Lopata A; Kellow G; Johnston I; Robinson HP
    Fertil Steril; 1981 Sep; 36(3):316-9. PubMed ID: 7286252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotrophin and steroid concentrations in follicular fluid: the relationship to oocyte maturity and fertilization rates in stimulated and natural in-vitro fertilization cycles.
    Enien WM; el Sahwy S; Harris CP; Seif MW; Elstein M
    Hum Reprod; 1995 Nov; 10(11):2840-4. PubMed ID: 8747029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient in vitro fertilization using transvaginal ultrasound-guided oocyte retrieval.
    Schulman JD; Dorfmann AD; Jones SL; Pitt CC; Joyce B; Patton LA
    Obstet Gynecol; 1987 Apr; 69(4):665-8. PubMed ID: 3103035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.
    Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G
    Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):167-73. PubMed ID: 6217993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):174-9. PubMed ID: 6401635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming with a gonadotropin-releasing hormone agonist before immature oocyte retrieval may improve maturity of oocytes and outcome in in vitro maturation (IVM) cycle: a case report.
    Smirnova A; Anshina M; Paz ES; Ellenbogen A
    J Med Case Rep; 2021 Mar; 15(1):134. PubMed ID: 33771223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturity and fertility of rhesus monkey oocytes collected at different intervals after an ovulatory stimulus (human chorionic gonadotropin) in in vitro fertilization cycles.
    Wolf DP; Alexander M; Zelinski-Wooten M; Stouffer RL
    Mol Reprod Dev; 1996 Jan; 43(1):76-81. PubMed ID: 8720116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human chorionic gonadotropin levels in the follicular fluid in relation to oocyte maturity in in vitro fertilization].
    Chen CF; Tsutsumi O; Fujiwara T; Mitsuhashi N; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):789-90. PubMed ID: 1890358
    [No Abstract]   [Full Text] [Related]  

  • 14. Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation induction: phase II--1981.
    Wortham JW; Veeck LL; Witmyer J; Sandow BA; Jones HW
    Fertil Steril; 1983 Aug; 40(2):170-7. PubMed ID: 6223843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation induction: Phase I--1981.
    Wortham JW; Veeck LL; Witmyer J; Jones HW
    Fertil Steril; 1983 Jun; 39(6):785-92. PubMed ID: 6406272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In Vitro Fertilization: beware of oocyte retrieval without oocyte!].
    Bringer-Deutsch S; Mayenga JM; Grefenstette I; Grzegorczyk V; Kulski O; Belaisch-Allart J
    Gynecol Obstet Fertil; 2010 Nov; 38(11):690-2. PubMed ID: 21115382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.
    Elias RT; Pereira N; Artusa L; Kelly AG; Pasternak M; Lekovich JP; Palermo GD; Rosenwaks Z
    J Assist Reprod Genet; 2017 Jun; 34(6):781-788. PubMed ID: 28444614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.